AAAAAA
Results: 26-50/63
Authors:
LANG CC
STEIN CM
HE HB
WOOD AJJ
Citation: Cc. Lang et al., ANGIOTENSIN-CONVERTING ENZYME-INHIBITION AND SYMPATHETIC ACTIVITY IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 59(6), 1996, pp. 668-674
Authors:
STEIN CM
BROWN N
CARLSON M
CAMPBELL P
WOOD AJJ
Citation: Cm. Stein et al., COADMINISTRATION OF GLYBURIDE AND MINOXIDIL, DRUGS WITH OPPOSING EFFECTS ON POTASSIUM CHANNELS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 39-39
Authors:
STEIN CM
NELSON R
HE HB
WOOD DM
WOOD AJJ
Citation: Cm. Stein et al., EFFECTS OF EPINEPHRINE ON NOREPINEPHRINE RELEASE, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 40-40
Authors:
LANG CC
STEIN CM
HE HB
WOOD AJJ
Citation: Cc. Lang et al., BLUNTED BLOOD-PRESSURE RESPONSE TO CENTRAL SYMPATHO-INHIBITION IN BLACKS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 45-45
Authors:
STEIN CM
KINIRONS MT
PINCUS T
WILKINSON GR
WOOD AJJ
Citation: Cm. Stein et al., COMPARISON OF THE DAPSONE RECOVERY RATIO AND THE ERYTHROMYCIN BREATH TEST AS IN-VIVO PROBES OF CYP3A ACTIVITY IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING CYCLOSPORINE, Clinical pharmacology and therapeutics, 59(1), 1996, pp. 47-51
Authors:
STEIN CM
BROOKS R
PINCUS T
Citation: Cm. Stein et al., EFFECT OF CYCLOSPORINE MEMOTREXATE (CYA+MTX) COMBINATION THERAPY IN RHEUMATOID-ARTHRITIS (RA) ON LIVER-FUNCTION TESTS/, Arthritis and rheumatism, 39(9), 1996, pp. 461-461
Authors:
STEIN CM
Citation: Cm. Stein, TOXICITY OF COMBINATION THERAPIES IN RHEUMATOID-ARTHRITIS - COMMENT, Arthritis and rheumatism, 39(8), 1996, pp. 1435-1436
Authors:
STEIN CM
TANNER SB
AWAD JA
ROBERTS LJ
MORROW JD
Citation: Cm. Stein et al., EVIDENCE OF FREE RADICAL-MEDIATED INJURY (ISOPROSTANE OVERPRODUCTION)IN SCLERODERMA, Arthritis and rheumatism, 39(7), 1996, pp. 1146-1150
Authors:
PINCUS T
STEIN CM
Citation: T. Pincus et Cm. Stein, WHAT IS THE BEST SOURCE OF USEFUL DATA ON THE TREATMENT OF RHEUMATOID-ARTHRITIS - CLINICAL-TRIALS, CLINICAL OBSERVATIONS, OR CLINICAL PROTOCOLS, Journal of rheumatology, 22(9), 1995, pp. 1611-1617
Authors:
STEIN CM
HE HB
PINCUS T
WOOD AJJ
Citation: Cm. Stein et al., CYCLOSPORINE IMPAIRS VASODILATION WITHOUT INCREASED SYMPATHETIC ACTIVITY IN HUMANS, Hypertension, 26(4), 1995, pp. 705-710
Authors:
STEIN CM
NELSON R
BROWN M
WOOD M
WOOD AJJ
Citation: Cm. Stein et al., DIETARY-SODIUM INTAKE MODULATES VASODILATION MEDIATED BY NITROPRUSSIDE BUT NOT BY METHACHOLINE IN THE HUMAN FOREARM, Hypertension, 25(6), 1995, pp. 1220-1223
Authors:
STEIN CM
NELSON R
DEEGAN R
HE HB
INAGAMI T
FRAZER M
BADR KF
WOOD M
WOOD AJJ
Citation: Cm. Stein et al., TACHYPHYLAXIS OF HUMAN FOREARM VASCULAR-RESPONSES DOES NOT OCCUR RAPIDLY AFTER EXPOSURE TO ISOPROTERENOL, Hypertension, 25(6), 1995, pp. 1294-1300
Authors:
LANG CC
STEIN CM
BROWN RM
DEEGAN R
NELSON R
HE HB
WOOD M
WOOD AJJ
Citation: Cc. Lang et al., ATTENUATION OF ISOPROTERENOL-MEDIATED VASODILATATION IN BLACKS, The New England journal of medicine, 333(3), 1995, pp. 155-160
Authors:
LANG CC
STEIN CM
WOOD AJJ
Citation: Cc. Lang et al., ATTENUATION OF ISOPROTERENOL-MEDIATED VASODILATATION IN BLACKS - REPLY, The New England journal of medicine, 333(22), 1995, pp. 1503-1503
Authors:
STEIN CM
NELSON R
DEEGAN R
HE HB
WOOD M
WOOD AJJ
Citation: Cm. Stein et al., FOREARM BETA-ADRENERGIC RECEPTOR-MEDIATED VASODILATION IS IMPAIRED, WITHOUT ALTERATION OF FOREARM NOREPINEPHRINE SPILLOVER, IN BORDERLINE HYPERTENSION, The Journal of clinical investigation, 96(1), 1995, pp. 579-585
Authors:
STEIN CM
NELSON R
BROWN M
HE HB
WOOD M
WOOD AJJ
Citation: Cm. Stein et al., DIETARY-SODIUM INTAKE MODULATES SYSTEMIC BUT NOT FOREARM NOREPINEPHRINE RELEASE, Clinical pharmacology and therapeutics, 58(4), 1995, pp. 425-433
Authors:
LANG CC
STEIN CM
NELSON R
HE HB
WOOD M
WOOD AJJ
Citation: Cc. Lang et al., EFFECTS OF ALPHA(2)-STIMULATION ARE BLUNTED IN CHRONIC HEART-FAILURE, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 142-142
Authors:
WOOD AJJ
STEIN CM
HE HB
LAN CC
Citation: Ajj. Wood et al., EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON SYMPATHETIC ACTIVITY IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 167-167
Authors:
STEIN CM
KINIRONS MT
PINCUS T
WILKINSON GR
WOOD AJJ
Citation: Cm. Stein et al., PHARMACOLOGICAL PROBES OF CYTOCHROME P4503A ACTIVITY AND CYCLOSPORINECONCENTRATIONS, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 192-192
Authors:
STEIN CM
NELSON R
DEEGAN R
HE HB
WOOD DM
WOOD AJJ
Citation: Cm. Stein et al., FOREARM BETA(2) RECEPTOR-MEDIATED VASODILATION IS IMPAIRED IN BORDERLINE HYPERTENSION, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 194-194
Authors:
LANG CC
STEIN CM
BROWN RM
DEEGAN R
NELSON R
WOOD AJJ
Citation: Cc. Lang et al., NORMOTENSIVE BLACKS HAVE IMPAIRED BETA(2)-ADRENOCEPTOR MEDIATED VASODILATION, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 205-205
Authors:
LANG CC
RAYOS GH
GOTHARD P
YEOH TK
STEIN CM
WOOD AJJ
WILSON JR
Citation: Cc. Lang et al., EFFECT OF SYMPATHOINHIBITION ON LIMB CIRCULATION AND METABOLISM DURING EXERCISE IN PATIENTS WITH HEART-FAILURE, Circulation, 92(8), 1995, pp. 3473-3473
Authors:
STEIN CM
Citation: Cm. Stein, CYCLOSPORINE IN THE TREATMENT OF RHEUMATOID-ARTHRITIS, Bulletin on rheumatic diseases, 44(7), 1995, pp. 1-4
Authors:
STEIN CM
TANNER BS
AWAD JA
ROBERTS LJ
MORROW JD
Citation: Cm. Stein et al., EVIDENCE FOR OXIDATIVE INJURY IN SCLERODERMA, Arthritis and rheumatism, 38(9), 1995, pp. 595-595
Authors:
PINCUS T
BROOKS RH
STEIN CM
Citation: T. Pincus et al., CHANGING PATTERNS OF PATIENT-CARE IN RHEUMATOID-ARTHRITIS - USE OF METHOTREXATE OR PREDNISONE IN GREATER-THAN-80-PERCENT (BOTH IN 57-PERCENT) OF PATIENTS AND FREQUENT COMBINATION THERAPY WITH MINIMAL EVIDENCE OF DISEASE IN 36-PERCENT OF PATIENTS, Arthritis and rheumatism, 38(9), 1995, pp. 1278-1278